Vertex Pharmaceuticals Incorpor

VRTX

$421.15

Name : Vertex Pharmaceuticals Incorpor

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $107,978,924,032.00

EPSttm : 14.07

Vertex Pharmaceuticals Incorpor

$421.15

2.65%

$10.87

Float Short %

1.59

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

0.4

EPS Last/This Y

20.1

EPS This/Next Y

2.18

Price

421.45

Target Price

487.04

Analyst Recom

1.86

Performance Q

-12.17

Relative Volume

1.05

Beta

0.35

Ticker: VRTX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	VRTX	396.34	0.63	1.56	47695
2025-09-10	VRTX	388.42	0.63	4.73	48400
2025-09-11	VRTX	397.1	0.63	9.33	48789
2025-09-12	VRTX	394.6	0.63	2.22	48957
2025-09-15	VRTX	393.22	0.63	4.09	47923
2025-09-16	VRTX	391.09	0.63	2.58	48510
2025-09-17	VRTX	387.15	0.62892748243404	3.1898089171975	49148
2025-09-18	VRTX	386.91	0.63	5.19	49223
2025-09-22	VRTX	382.95	0.60	1.45	41251
2025-09-23	VRTX	379.02	0.59	1.41	42651
2025-09-24	VRTX	375.74	0.59	0.26	43148
2025-09-25	VRTX	381.91	0.58	0.53	43681
2025-09-26	VRTX	386.41	0.57	1.08	44586
2025-09-29	VRTX	395.37	0.55	1.21	42825
2025-09-30	VRTX	391.64	0.56	0.61	44335
2025-10-01	VRTX	404.14	0.56	0.44	45103
2025-10-02	VRTX	408.87	0.56	3.40	46990
2025-10-03	VRTX	403.26	0.57	0.75	47841
2025-10-06	VRTX	402.91	0.57	0.23	46022
2025-10-07	VRTX	410.12	0.56	0.49	46565
2025-10-08	VRTX	421.29	0.56	0.93	47304
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	VRTX	396.44	5.3	1824.6	18.03
2025-09-10	VRTX	388.46	5.3	1673.4	18.03
2025-09-11	VRTX	397.37	5.3	1952.8	18.03
2025-09-12	VRTX	394.51	5.3	1758.1	18.03
2025-09-15	VRTX	392.88	5.3	1777.8	18.03
2025-09-16	VRTX	391.36	5.3	1774.4	18.03
2025-09-17	VRTX	387.11	5.3	1734.3	18.03
2025-09-18	VRTX	387.05	5.3	1803.3	18.03
2025-09-19	VRTX	383.07	5.3	1737.0	18.03
2025-09-22	VRTX	383.13	5.3	1803.3	18.03
2025-09-23	VRTX	379.61	5.3	1745.1	18.03
2025-09-24	VRTX	376.64	5.3	1752.1	18.03
2025-09-25	VRTX	381.87	5.3	1895.9	18.03
2025-09-26	VRTX	385.73	5.3	1870.9	18.03
2025-09-29	VRTX	395.39	5.2	1968.1	18.03
2025-09-30	VRTX	391.57	5.2	1743.4	18.03
2025-10-01	VRTX	404.10	5.2	2012.1	18.03
2025-10-02	VRTX	408.99	5.2	1881.8	18.03
2025-10-03	VRTX	403.26	5.2	1716.2	18.03
2025-10-06	VRTX	402.90	5.1	1710.4	18.03
2025-10-07	VRTX	410.12	5.1	1921.5	18.02
2025-10-08	VRTX	421.45	5.1	1981.8	18.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	VRTX	0.16	0.29	1.45
2025-09-10	VRTX	0.16	0.29	1.45
2025-09-11	VRTX	0.16	0.29	1.42
2025-09-12	VRTX	0.16	0.29	1.42
2025-09-15	VRTX	1.37	0.29	1.42
2025-09-16	VRTX	1.37	0.29	1.42
2025-09-17	VRTX	1.37	0.29	1.42
2025-09-18	VRTX	1.77	0.29	1.42
2025-09-19	VRTX	1.77	0.29	1.42
2025-09-22	VRTX	1.77	0.29	1.42
2025-09-23	VRTX	1.77	0.29	1.42
2025-09-24	VRTX	1.77	0.29	1.42
2025-09-25	VRTX	1.77	0.29	1.59
2025-09-26	VRTX	1.77	0.29	1.59
2025-09-29	VRTX	1.77	0.28	1.59
2025-09-30	VRTX	1.89	0.28	1.59
2025-10-01	VRTX	1.89	0.28	1.59
2025-10-02	VRTX	1.89	0.28	1.59
2025-10-03	VRTX	1.80	0.28	1.59
2025-10-06	VRTX	1.80	0.36	1.59
2025-10-07	VRTX	1.80	0.36	1.59
2025-10-08	VRTX	1.80	0.36	1.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

4.52

Avg. EPS Est. Current Quarter

4.61

Avg. EPS Est. Next Quarter

4.92

Insider Transactions

1.8

Institutional Transactions

0.36

Beta

0.35

Average Sales Estimate Current Quarter

3054

Average Sales Estimate Next Quarter

3211

Fair Value

493.39

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.9

Max Drawdown 5-Year %

-35.9

Target Price

487.04

P/E

30.1

Forward P/E

20.49

PEG

P/S

9.48

P/B

6.28

P/Free Cash Flow

30.85

EPS

13.99

Average EPS Est. Cur. Y

18.02

EPS Next Y. (Est.)

20.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

31.92

Relative Volume

1.05

Return on Equity vs Sector %

-4

Return on Equity vs Industry %

9.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

1981.8

Vertex Pharmaceuticals Incorpor

Sector: Healthcare

Industry: Biotechnology

Employees: 6100

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of sickle cell disease and transfusion-dependent beta thalassemia; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease which is in single Phase 2; VX-880 and VX-264, treatment for Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

stock quote shares VRTX – Vertex Pharmaceuticals Incorporated Stock Price stock today

news today VRTX – Vertex Pharmaceuticals Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch VRTX – Vertex Pharmaceuticals Incorporated yahoo finance google finance

stock history VRTX – Vertex Pharmaceuticals Incorporated invest stock market

stock prices VRTX premarket after hours

ticker VRTX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VRTX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y